ProPhase Labs, Inc. (OTC: PRPH) updated shareholders on recent trading activity, capital structure changes, and asset base. Volatility in stock price attributed to debt conversion, stock split, and market transition. $3.3 million of $3.8 million debt converted, reducing liabilities and increasing equity. Remaining debt balance less than $500,000. Recent conversions occurred at $0.76 per share. Share count increased but debt reduced on dollar-for-dollar basis. CEO emphasized that underlying asset value remains unchanged. Company focuses on stabilizing capital structure, financing, and core business operations. ProPhase Labs committed to transparent communication with shareholders.

ProPhase Labs Inc. (OTC: PRPH) is a biotech, genomics, and consumer products company. Company develops, manufactures, and commercializes health and wellness solutions. Recent market activity focused on share count changes; intrinsic value of assets unaffected. Capital structure actions do not change underlying asset value. Recent debt conversion strengthened balance sheet. Company remains committed to long-term value. ProPhase Labs’ subsidiaries and omni-channel approach underscore potential for growth. Forward-looking statements highlight strategy, initiatives, and potential risks. Company aims to revolutionize healthcare with innovative solutions and actionable insights.

Read more at GlobeNewswire: ProPhase Labs Provides Update on Convertible Debt